0001649094-24-000039.txt : 20240724 0001649094-24-000039.hdr.sgml : 20240724 20240724174405 ACCESSION NUMBER: 0001649094-24-000039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240723 FILED AS OF DATE: 20240724 DATE AS OF CHANGE: 20240724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PICKERING GRANT CENTRAL INDEX KEY: 0001258693 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39323 FILM NUMBER: 241139195 MAIL ADDRESS: STREET 1: C/O VAXCYTE, INC. STREET 2: 825 INDUSTRIAL ROAD, STE. 300 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxcyte, Inc. CENTRAL INDEX KEY: 0001649094 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464233385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 825 INDUSTRIAL ROAD, STE. 300 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-837-0111 MAIL ADDRESS: STREET 1: 825 INDUSTRIAL ROAD, STE. 300 CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: SutroVax, Inc. DATE OF NAME CHANGE: 20150724 4 1 wk-form4_1721857439.xml FORM 4 X0508 4 2024-07-23 0 0001649094 Vaxcyte, Inc. PCVX 0001258693 PICKERING GRANT C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 1 1 0 0 CHIEF EXECUTIVE OFFICER 1 Common Stock 2024-07-23 4 M 0 15000 2.03 A 493888 D Common Stock 2024-07-23 4 S 0 5718 83.827 D 488170 D Common Stock 2024-07-23 4 S 0 9282 84.528 D 478888 D Common Stock 143438 I By Children's Trust Common Stock 143438 I By Children's Trust Stock Option (right to buy) 2.03 2024-07-23 4 M 0 15000 0 D 2028-07-23 Common Stock 15000 182327 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023. The price reported is a weighted-average price. The shares were sold at prices ranging from $83.17 to $84.145. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The price reported is a weighted-average price. The shares were sold at prices ranging from $84.175 to $84.98. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Shares are held directly by a trust for the benefit of the Reporting Person's daughter. Shares are held directly by a trust for the benefit of the Reporting Person's son. Stock Option is fully vested and exercisable. Grant Pickering, by /s/ Peter N. Efremenko, Attorney-In-Fact 2024-07-24